Augmentin '125' and Warm type haemolytic anaemia - a phase IV clinical study of FDA data
Warm type haemolytic anaemia is reported only by a few people who take Augmentin '125'.
The phase IV clinical study analyzes which people take Augmentin '125' and have Warm type haemolytic anaemia. It is created by eHealthMe based on reports of 10,373 people who have side effects while taking Augmentin '125' from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
10,373 people reported to have side effects when taking Augmentin '125'.
Among them, 1 person (0.01%) has Warm type haemolytic anaemia.
What is Augmentin '125'?
Augmentin '125' has active ingredients of amoxicillin; clavulanate potassium. It is often used in sinusitis. eHealthMe is studying from 10,452 Augmentin '125' users for its effectiveness, alternative drugs and more.
What is Warm type haemolytic anaemia?
Warm type haemolytic anaemia (red cell destruction due to warm antibody self defence) is found to be associated with 171 drugs and 116 conditions by eHealthMe.
Number of Augmentin '125' and Warm type haemolytic anaemia reports submitted per year:
Time on Augmentin '125' when people have Warm type haemolytic anaemia *:
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Warm type haemolytic anaemia when taking Augmentin '125' *:
- female: 0.0 %
- male: 100 %
Age of people who have Warm type haemolytic anaemia when taking Augmentin '125' *:
- 0-1: 0.0 %
- 2-9: 100 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 0.0 %
Common conditions people have *:
- Acute Tonsillitis: 1 person, 100.00%
* Approximation only. Some reports may have incomplete information.
Do you take Augmentin '125' and have Warm type haemolytic anaemia?Check whether Warm type haemolytic anaemia is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Warm type haemolytic anaemia and when was it recovered:
Expand to all the drugs that have ingredients of amoxicillin; clavulanate potassium:
- Warm type haemolytic anaemia and drugs with ingredients of amoxicillin; clavulanate potassium (1 reports)
Alternative drugs to, pros and cons of Augmentin '125':
- Augmentin '125' (10,452 reports)
Common Augmentin '125' side effects:
- Fever: 1,203 reports
- Rashes (redness): 1,137 reports
- Pain: 919 reports
- Breathing difficulty: 906 reports
- Diarrhea: 881 reports
- Nausea and vomiting: 805 reports
Browse all side effects of Augmentin '125':a b c d e f g h i j k l m n o p q r s t u v w x y z
Warm type haemolytic anaemia treatments and more:
- Warm type haemolytic anaemia (205 reports)
COVID vaccines that are related to Warm type haemolytic anaemia:
- Warm type haemolytic anaemia in Moderna COVID Vaccine
- Warm type haemolytic anaemia in Pfizer BioNTech Covid Vaccine
- Warm type haemolytic anaemia in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Warm type haemolytic anaemia:
- Warm type haemolytic anaemia (171 drugs)
All the conditions that are associated with Warm type haemolytic anaemia:
- Warm type haemolytic anaemia (116 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on amoxicillin; clavulanate potassium (the active ingredients of Augmentin '125') and Augmentin '125' (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Qvar Redihaler and Loss Of Consciousness - 2 seconds ago
- Phenergan and Alopecia Areata - 11 seconds ago
- Melphalan and Innohep drug interaction - 12 seconds ago
- Sennosides and Fosphenytoin Sodium drug interaction - 15 seconds ago
- White Blood Cell Count Increased and drugs of ingredients of cabergoline - 19 seconds ago
- Minoxidil and Ampicillin Sodium drug interaction - 21 seconds ago
- Eylea and Memory Loss - 25 seconds ago
- Lorazepam and Lichen Planus Aggravated - 27 seconds ago
- Tamoxifen Citrate and Lack Of Spontaneous Speech - 31 seconds ago
- Zyrtec and Nonspecific Reaction - 44 seconds ago